5 results
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Crizotinib in Untreated ALK-Positive ... Lung Cancer #EBM #Honc ... Alectinib #Crizotinib #ALK ... #ALKPositive #NSCLC ... VisualAbstract #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
the Intention-to-Treat ... #EBM #Honc #PACIFIC ... #Durvalumab #NSCLC ... #NEJM
Diagnostic Algorithm for Non–Small-Cell Lung Cancer (NSCLC). The upper portion of the algorithm shows the morphologic
classification of NSCLC ... mutations and ALK ... #Diagnosis #Honc ... #Algorithm #NSCLC ... #PDL1 #NEJM
Radiation-Induced Angiosarcoma after Breast-Cancer Treatment - Physical examination revealed an area of skin 10 cm in
Angiosarcoma after Breast-Cancer ... the dermis and breast ... Clinical #Derm #Honc ... #Radiation #Microscopy ... #NEJM
Perirenal Extramedullary Hematopoiesis - Magnetic resonance imaging of the abdomen, performed without the administration of contrast
hemosiderin deposition, all ... Radiology #Pathology #Honc ... ExtramedullaryHematopoiesis #Microscopy ... #NEJM